Closing the Door on 2011

December - 31 - 2011

Well, what a year it has been. If you have been out of the markets for past 12 months then you may think nothing had happened when you look at EURUSD, which is set to closer the year a mere 3% lower than where it opened. Likewise, the S&P 500

Closing the Door on 2011

December - 31 - 2011

Well, what a year it has been. If you have been out of the markets for past 12 months then you may think nothing had happened when you look at EURUSD, which is set to closer the year a mere 3% lower than where it opened. Likewise, the S&P 500

Business Highlights

December - 30 - 2011

___After many ups and downs, stocks end flat for 2011NEW YORK — The stock market ended a tumultuous year right where it started.In the final tally, despite big climbs and falls, unexpected blows and surprising …

For the U.S. stock market, 2011 was a long wild ride to nowhere. The broad S&P 500 endured huge daily swings but a year of drama left the index almost where it started. It lost a mere 0.003 percent, closest …

Stocks ending flat for year after big ups, downsThe stock market is ending a tumultuous year right where it started.The Standard & Poor’s 500 index closed 2011 a fraction of a point below where it started the year. The S&P closed at 1,257.60, up 5.42 …

STOCKS FLAT: Despite a tumultuous ride, the S&P 500 index closed nearly unchanged for 2011. It ended at 1,257.60 Friday, just 0.04 point below where it started the year.BEST OF THE BAD: U.S. stocks delivered …

After many ups and downs, stocks end flat for 2011The stock market ended a tumultuous year right where it started.In the final tally, despite big climbs and falls, unexpected blows and surprising triumphs, all the hullabaloo proved for naught. On Friday, …

The equity markets and broad stock exchange traded funds (ETFs) ended December and the year, mixed.  The Dow Jones industrial average was up 1.4% for the month and up 5.5% for the year.  The S&P 500 gain …

SUBSCRIBE

Sign up today for our free weekly newsletter.

Weight Loss Drugs: Why Arena’s Is Likely To Win Approval Before Vivus’s

By KLLJ Investments:
Will a new weight loss drug be approved in 2012?
Here we are, two months into 2012 and the FDA has another opportunity to approve a new drug to help fight obesity. Will [...]

Why Vestas Is Undervalued

By Mike Arnold:
Every security is a sell at one price, a hold at some lower price and a buy at yet some further decremented price when value is appreciably higher than the stock quote. Before [...]

How To Play Peak Cheap Oil: Looking For Yield And Growth In The Canadian Oil Sands

By Bayesian Investing:
If you are like me and you were always skeptical of the peak oil theory, you are feeling pretty smug right now. New technologies and new oil discoveries are being made daily and [...]

Use The QQQ To Take A Bite Of Apple While Limiting Single Stock Risk

By Anthony Welch:
With the recent talk of rebalancing the NASDAQ once again due to ongoing outperformance of Apple (AAPL) versus the other constituents of the index, one decision ETF investors face is whether to [...]